COM:SANA
Sana Biotechnology, Inc.
- Stock
Last Close
2.35
22/11 21:00
Market Cap
1.15B
Beta: -
Volume Today
1.82M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 144.50K - | 1.13M 679.58% | 2.24M 98.49% | 2.54M 13.51% | 3.48M 37.21% | ||
average receivables | |||||||
book value per share | -1.09 - | -2.40 119.56% | 4.38 282.20% | 2.65 39.43% | 1.48 44.25% | ||
capex per share | -0.20 - | -0.14 32.25% | -0.18 31.77% | -0.11 38.22% | -0.10 7.10% | ||
capex to depreciation | -14.34 - | -4.03 71.88% | -2.70 33.09% | -1.34 50.47% | -0.65 51.42% | ||
capex to operating cash flow | 0.31 - | 0.17 43.50% | 0.12 31.25% | 0.07 39.49% | 0.08 9.76% | ||
capex to revenue | |||||||
cash per share | 1.07 - | 3.80 255.77% | 3.31 12.78% | 2.25 32.01% | 1.07 52.27% | ||
days of inventory on hand | |||||||
days payables outstanding | 48.58 - | ||||||
days sales outstanding | |||||||
debt to assets | 0.12 - | 0.10 15.09% | 0.10 0.24% | 0.13 33.95% | 0.18 39.95% | ||
debt to equity | -0.34 - | -0.17 49.52% | 0.15 189.20% | 0.22 42.36% | 0.36 67.00% | ||
dividend yield | |||||||
earnings yield | -0.03 - | -0.05 58.31% | -0.13 195.03% | -0.36 168.03% | -0.36 0.34% | ||
enterprise value | -30.63M - | 4.54B 14,923.83% | 5.81B 28.03% | 2.43B 58.13% | 675.45M 72.25% | 760.47M 12.59% | |
enterprise value over ebitda | -32.59 - | -20.32 37.66% | -6.82 66.43% | -2.48 63.67% | -2.58 4.05% | ||
ev to operating cash flow | -53.10 - | -42.13 20.66% | -9.70 76.99% | -2.33 75.98% | -3.00 28.78% | ||
ev to sales | |||||||
free cash flow per share | -0.86 - | -0.92 7.68% | -1.69 82.82% | -1.65 2.19% | -1.41 14.80% | ||
free cash flow yield | -0.02 - | -0.03 7.68% | -0.11 314.54% | -0.42 283.30% | -0.34 17.52% | ||
graham net net | -3.22 - | -2.77 13.86% | 0.90 132.53% | 0.53 40.80% | -0.35 166.21% | ||
graham number | 4.97 - | 9.27 86.44% | 14.27 53.97% | 9.19 35.64% | 6.96 24.25% | ||
income quality | 0.65 - | 0.48 26.03% | 0.71 45.85% | 1.08 52.60% | 0.90 16.83% | ||
intangibles to total assets | 0 - | 0.48 Infinity% | 0.27 43.08% | 0.18 35.34% | 0.24 37.28% | 0.35 45.54% | |
interest coverage | 17.44 - | ||||||
interest debt per share | 0.37 - | 0.41 10.84% | 0.67 62.52% | 0.49 26.22% | 0.54 8.80% | ||
inventory turnover | |||||||
invested capital | -0.34 - | -0.17 49.52% | 0.15 189.20% | 0.22 42.36% | 0.36 67.00% | ||
market cap | 4.57B - | 6.15B 34.58% | 2.58B 58.13% | 743.96M 71.12% | 793.73M 6.69% | ||
net current asset value | -14.93M - | -413.98M 2,673.72% | -767.01M 85.28% | 157.20M 120.49% | 121.03M 23.01% | -64.28M 153.11% | |
net debt to ebitda | 0.23 - | 1.19 420.34% | 0.40 66.50% | 0.25 36.86% | 0.11 55.15% | ||
net income per share | -1.00 - | -1.59 58.31% | -2.07 30.12% | -1.41 31.61% | -1.46 2.94% | ||
operating cash flow per share | -0.66 - | -0.79 19.91% | -1.51 91.66% | -1.54 2.09% | -1.30 15.36% | ||
payables turnover | 7.51 - | ||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.61 - | -0.53 13.29% | -0.37 29.51% | -0.43 15.50% | -0.78 81.23% | ||
revenue per share | |||||||
roe | 0.92 - | 0.66 27.89% | -0.47 171.42% | -0.53 12.92% | -0.99 84.67% | ||
roic | 2.89 - | 1.01 65.17% | -0.36 136.04% | -0.38 3.65% | -0.68 79.39% | ||
sales general and administrative to revenue | |||||||
shareholders equity per share | -1.09 - | -2.40 119.56% | 4.38 282.20% | 2.65 39.43% | 1.48 44.25% | ||
stock based compensation to revenue | |||||||
tangible asset value | -13.19M - | -342.36M 2,496.03% | -621.01M 81.39% | 528.68M 185.13% | 299.49M 43.35% | 87.68M 70.72% | |
tangible book value per share | -2.63 - | -3.54 34.78% | 3.18 189.68% | 1.59 49.94% | 0.45 71.66% | ||
working capital | 30.81M - | 124.43M 303.86% | 353.02M 183.70% | 458.87M 29.98% | 332.93M 27.44% | 149.03M 55.24% |
All numbers in USD (except ratios and percentages)